Form 8-K - Current report:
SEC Accession No. 0000831547-22-000025
Filing Date
2022-05-05
Accepted
2022-05-05 16:11:57
Documents
14
Period of Report
2022-05-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K sppi-20220504.htm   iXBRL 8-K 41340
2 EX-99.1 sppispectrumpharma-brittan.htm EX-99.1 11384
6 image_0a.jpg GRAPHIC 18091
  Complete submission text file 0000831547-22-000025.txt   225211

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sppi-20220504.xsd EX-101.SCH 1921
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sppi-20220504_lab.xml EX-101.LAB 25293
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sppi-20220504_pre.xml EX-101.PRE 13198
8 EXTRACTED XBRL INSTANCE DOCUMENT sppi-20220504_htm.xml XML 11331
Mailing Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052
Business Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052 702-835-6300
SPECTRUM PHARMACEUTICALS INC (Filer) CIK: 0000831547 (see all company filings)

IRS No.: 930979187 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35006 | Film No.: 22896367
SIC: 2834 Pharmaceutical Preparations